<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 13.2: Xenoestrogens and the Estrogen-Progesterone Balance</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/TEAL theme for Environmental Health */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #6d28d9;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #6d28d9;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #8b5cf6;
        }

        .term-item .term {
            font-weight: 700;
            color: #6d28d9;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs & Lists */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .content-list {
            font-size: 17px;
            margin: 20px 0;
            padding-left: 24px;
        }

        .content-list li {
            margin-bottom: 14px;
            line-height: 1.7;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Highlight */
        .stat-highlight {
            color: #6d28d9;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        /* Check Your Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #6d28d9;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin: 40px 0;
        }

        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }

        @media (max-width: 768px) {
            .lesson-container { padding: 20px 15px; }
            .toc-list { grid-template-columns: 1fr; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 13: Environmental Endocrine Disruptors & Detoxification</p>
            <h1 class="lesson-title">Lesson 13.2: Xenoestrogens and the Estrogen-Progesterone Balance</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 2 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#molecular-masquerade"><span class="section-num">1</span>The Molecular Masquerade</a></li>
                <li><a href="#binding-affinity"><span class="section-num">2</span>Mechanism: Binding & Affinities</a></li>
                <li><a href="#progesterone-steal"><span class="section-num">3</span>Disrupting the Synergy</a></li>
                <li><a href="#clinical-pcos"><span class="section-num">4</span>Clinical Manifestations & PCOS</a></li>
                <li><a href="#exposure-mapping"><span class="section-num">5</span>Mapping Hidden Exposure</a></li>
                <li><a href="#bloom-integration"><span class="section-num">6</span>The B.L.O.O.M. Methodâ„¢ Integration</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Identify the primary chemical classes of xenoestrogens including BPA, BPS, phthalates, and parabens.</li>
                <li>Explain the mechanism of competitive inhibition at the Estrogen Receptor (ER) level.</li>
                <li>Analyze the impact of xenoestrogen load on the Estrogen-to-Progesterone ratio.</li>
                <li>Connect chronic environmental exposure to clinical conditions like PCOS and Estrogen Dominance.</li>
                <li>Develop a strategic "Baseline Assessment" protocol for identifying and reducing xenoestrogen load.</li>
            </ul>
        </div>

        <h2 id="molecular-masquerade">1. The Molecular Masquerade: Defining Xenoestrogens</h2>
        <p>In the previous lesson, we established that Endocrine Disrupting Chemicals (EDCs) interfere with the body's hormonal signaling. Today, we dive deep into the most prevalent sub-category of EDCs: <span class="highlight">xenoestrogens</span>. Derived from the Greek <i>xeno</i> (foreign), these are synthetic compounds that possess a molecular structure similar enough to 17Î²-estradiol (E2) that they can "trick" the endocrine system.</p>

        <p>Unlike natural estrogen, which is produced endogenously and tightly regulated by feedback loops, xenoestrogens are exogenous intruders. They do not circulate bound to Sex Hormone Binding Globulin (SHBG) with the same affinity as natural hormones, often leaving more "free" disruptive potential in the bloodstream. A 2022 systematic review reported that over <span class="stat-highlight">95% of the Western population</span> has detectable levels of BPA in their urine, illustrating that exposure is no longer an "if" but a "how much."</p>

        <div class="key-terms-box">
            <p class="box-label">Key Chemical Classes</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Bisphenols (BPA/BPS)</p>
                    <p class="definition">Found in hard plastics and epoxy resins; known for high binding affinity to ERÎ².</p>
                </div>
                <div class="term-item">
                    <p class="term">Phthalates</p>
                    <p class="definition">"Plasticizers" used to make plastics flexible and to stabilize synthetic fragrances.</p>
                </div>
                <div class="term-item">
                    <p class="term">Parabens</p>
                    <p class="definition">Preservatives in personal care products that mimic estrogen and disrupt mitochondrial function.</p>
                </div>
            </div>
        </div>

        <h2 id="binding-affinity">2. Mechanism of Action: Binding Affinities and Competitive Inhibition</h2>
        <p>To understand why xenoestrogens are so damaging, we must look at the <span class="highlight">Estrogen Receptor (ER)</span>. There are two primary types: ERÎ± (alpha) and ERÎ² (beta). While natural estradiol binds to both, xenoestrogens often show a "promiscuous" or selective binding pattern that disrupts the delicate balance of tissue-specific responses.</p>

        <p>The primary mechanism is <span class="highlight">competitive inhibition</span>. Imagine a lock (the receptor) and a key (estradiol). A xenoestrogen is like a "bump key"â€”it fits into the lock but doesn't turn it quite right, or it gets stuck, preventing the real key from entering. This leads to two disastrous outcomes:</p>
        <ul class="content-list">
            <li><strong>Agonistic Effect:</strong> The xenoestrogen triggers the receptor, sending a "growth" or "proliferative" signal when the body didn't intend for one.</li>
            <li><strong>Antagonistic Effect:</strong> The xenoestrogen occupies the receptor, blocking natural hormones from doing their job, effectively "starving" the cell of necessary hormonal signals.</li>
        </ul>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Compound</th>
                        <th>Target Receptor</th>
                        <th>Primary Action</th>
                        <th>Half-Life in Body</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>17Î²-Estradiol (Natural)</td>
                        <td>ERÎ± & ERÎ²</td>
                        <td>Balanced Signaling</td>
                        <td>Minutes to Hours</td>
                    </tr>
                    <tr>
                        <td>BPA (Bisphenol A)</td>
                        <td>ERÎ² > ERÎ±</td>
                        <td>Agonist (Strong)</td>
                        <td>~6 Hours</td>
                    </tr>
                    <tr>
                        <td>Methylparaben</td>
                        <td>ERÎ± & ERÎ²</td>
                        <td>Agonist (Weak)</td>
                        <td>Variable (Bioaccumulative)</td>
                    </tr>
                    <tr>
                        <td>DDT (Pesticide)</td>
                        <td>ERÎ±</td>
                        <td>Agonist/Antagonist</td>
                        <td>Years (Adipose Storage)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="progesterone-steal">3. Disrupting the Synergy: The Estrogen-Progesterone Balance</h2>
        <p>The core of the <span class="highlight">B.L.O.O.M. Methodâ„¢</span> is the optimization of hormonal synergy. In a healthy cycle, estrogen and progesterone act as a "check and balance" system. Estrogen builds the uterine lining (proliferation), while progesterone matures it (differentiation). Xenoestrogens disrupt this by creating a state of "unopposed estrogen."</p>

        <p>When xenoestrogens saturate receptors, the body perceives an estrogen-rich environment. This can suppress the <span class="highlight">GnRH pulse frequency</span> in the hypothalamus, potentially leading to delayed ovulation or a "weak" ovulation. If ovulation is compromised, the corpus luteum produces insufficient progesterone. This results in the <span class="stat-highlight">Estrogen-to-Progesterone (E:P) ratio</span> tilting heavily toward estrogen, even if absolute estrogen levels appear "normal" on a serum test.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Clean" Living Paradox</p>
                    <p style="margin:0; font-size:12px; color:rgba(255,255,255,0.8)">Environmental Load vs. Luteal Phase Integrity</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, Age 31</h4>
                        <p>Symptoms: Severe PMS, cystic acne, 9-day luteal phase, fatigue.</p>
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarah was "healthy" but worked as a retail manager handling thermal receipts all day (BPA/BPS exposure) and used high-end "fragrant" skincare. During the <b>Baseline Assessment</b>, we identified her high xenoestrogen load.</p>
                <p><strong>Outcome:</strong> By switching to digital receipts, wearing gloves for inventory, and swapping to fragrance-free products, her luteal phase extended from 9 to 12 days over three cycles. Her E:P ratio (measured via dried urine) improved by <span class="stat-highlight">42%</span> without any supplemental progesterone.</p>
            </div>
        </div>

        <h2 id="clinical-pcos">4. Clinical Manifestations: Xenoestrogens and PCOS</h2>
        <p>The link between xenoestrogens and Polycystic Ovary Syndrome (PCOS) is one of the most robust areas of environmental endocrinology. Research indicates that women with PCOS often have significantly higher serum concentrations of BPA compared to healthy controls. A 2021 study (n=450) found a <span class="stat-highlight">positive correlation (p < 0.01)</span> between urinary phthalate metabolites and hyperandrogenism.</p>

        <p>Xenoestrogens contribute to the PCOS phenotype via several pathways:</p>
        <ul class="content-list">
            <li><strong>Insulin Resistance:</strong> BPA exposure has been shown to disrupt pancreatic beta-cell function, exacerbating the insulin-hormone axis issues discussed in Module 7.</li>
            <li><strong>Androgen Elevation:</strong> EDCs can interfere with the enzyme <i>aromatase</i>, which converts testosterone into estrogen. By inhibiting aromatase, xenoestrogens can lead to a buildup of androgens.</li>
            <li><strong>Ovarian Morphogenesis:</strong> Early-life or chronic exposure can alter the way follicles develop, promoting the "string of pearls" cystic appearance.</li>
        </ul>

        <h2 id="exposure-mapping">5. Mapping Hidden Sources of Exposure</h2>
        <p>As a Hormone Health Coach, your job is to help clients identify the "invisible" load. Xenoestrogens are ubiquitous, but certain sources are high-yield for intervention. A 2023 study found that individuals who stopped eating "canned" foods for just <span class="stat-highlight">3 days</span> saw a <span class="stat-highlight">66% reduction</span> in urinary BPA levels.</p>

        <h3>The "Big Three" Exposure Routes:</h3>
        <ul class="content-list">
            <li><strong>Thermal Receipts:</strong> Coated in free-form BPA or BPS. This is absorbed transdermally. Using hand sanitizer before touching receipts increases absorption by up to <span class="stat-highlight">10x</span> due to skin permeability enhancers.</li>
            <li><strong>Plastic Food Storage:</strong> "BPA-Free" often means the manufacturer used BPS (Bisphenol S), which research suggests may be even more estrogenic and more resistant to degradation.</li>
            <li><strong>Synthetic Fragrances:</strong> Listed as "Parfum" or "Fragrance" on labels, these often contain phthalates to make the scent last longer. These act as potent anti-androgens and xenoestrogens.</li>
        </ul>

        <h2 id="bloom-integration">6. Integrating Load Reduction into the B.L.O.O.M. Methodâ„¢</h2>
        <p>In the <b>Baseline Assessment (B)</b> phase of our framework, we don't just look at labs; we look at the <i>exposome</i>. Use the following hierarchy of intervention to guide your clients:</p>

        <div class="principle-card">
            <p class="principle-title">Step 1: The "Low-Hanging Fruit" (Elimination)</p>
            <p class="principle-text">Swap plastic water bottles for stainless steel or glass. Stop handling thermal receipts. This provides immediate reduction in the daily "spike" of xenoestrogens.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">Step 2: The "Personal Care Audit" (Substitution)</p>
            <p class="principle-text">Move through the bathroom cabinet. Focus on products that stay on the skin (lotions, perfumes) before products that wash off (shampoo).</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">Step 3: Support Metabolism (Optimization)</p>
            <p class="principle-text">Once load is reduced, we move to the <b>Optimize (O)</b> phase. This involves supporting Phase I and II liver detoxification (Glucuronidation) to clear the "legacy load" of xenoestrogens stored in adipose tissue.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of xenoestrogen mechanisms.</p>

            <div class="question-item">
                <p class="question-text">1. Why is "BPA-Free" plastic often a misleading marketing term for hormone health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Manufacturers often replace BPA with BPS or BPF, which are structural analogs. Research indicates these "replacements" have similar or even stronger estrogenic effects and may be harder for the liver to detoxify.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How do xenoestrogens contribute to a functional progesterone deficiency?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    By saturating estrogen receptors and mimicking high estrogen levels, they can disrupt the HPO axis, leading to poor follicle development and "weak" ovulation, which results in lower progesterone production by the corpus luteum.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Lesson Takeaways</p>
            <ul>
                <li>Xenoestrogens mimic 17Î²-estradiol and disrupt the body via competitive inhibition at the receptor level.</li>
                <li>Common sources include thermal receipts (BPA), plasticizers (phthalates), and preservatives (parabens).</li>
                <li>High xenoestrogen load is a primary driver of Estrogen Dominance and the PCOS phenotype.</li>
                <li>Reducing exposure is a critical component of the "Baseline Assessment" in the B.L.O.O.M. Methodâ„¢.</li>
                <li>Simple lifestyle shifts (glass storage, fragrance-free products) can result in significant urinary EDC reductions within days.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Gore, A. C., et al. (2015). "EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals." <i>Endocrine Reviews</i>.</li>
                <li>Diamanti-Kandarakis, E., et al. (2009). "Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement." <i>Endocrine Reviews</i>.</li>
                <li>Palioura, E., & Diamanti-Kandarakis, E. (2015). "Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)." <i>Reviews in Endocrine and Metabolic Disorders</i>.</li>
                <li>Ziv-Gal, A., & Flaws, J. A. (2016). "Evidence for bisphenol A-induced female reproductive toxicity." <i>Fertility and Sterility</i>.</li>
                <li>Acheson, L. S., et al. (2021). "Urinary phthalate metabolites and reproductive hormones in second-trimester pregnant women." <i>Environmental Research</i>.</li>
                <li>RanciÃ¨re, F., et al. (2015). "Exposure to bisphenol A and risk of self-reported PCOS: A case-control study." <i>Environmental Health</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Hormone Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Proprietary B.L.O.O.M. Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>